GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Life Sciences Ltd (BOM:530239) » Definitions » 5-Year Dividend Growth Rate

Suven Life Sciences (BOM:530239) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Suven Life Sciences 5-Year Dividend Growth Rate?

Suven Life Sciences's Dividends per Share for the three months ended in Sep. 2024 was ₹0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Suven Life Sciences was 100.10% per year. The lowest was -9.10% per year. And the median was 6.30% per year.

Suven Life Sciences's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00. As of today, Suven Life Sciences's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Suven Life Sciences's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Suven Life Sciences's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suven Life Sciences's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suven Life Sciences's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Suven Life Sciences's 5-Year Dividend Growth Rate falls into.



Suven Life Sciences 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Suven Life Sciences  (BOM:530239) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Suven Life Sciences's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0/ -2.27
=N/A

During the past 13 years, the highest Dividend Payout Ratio of Suven Life Sciences was 0.34. The lowest was 0.15. And the median was 0.19.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of Suven Life Sciences was 14.62%. The lowest was 0.00%. And the median was 8.99%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suven Life Sciences 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Suven Life Sciences's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Suven Life Sciences Business Description

Traded in Other Exchanges
Address
Avenue 7, Road No. 5, Banjara Hills, Number 8-2-334, 6th Floor, SDE Serene Chambers, Hyderabad, TG, IND, 500 034
Suven Life Sciences Ltd is an India-based biopharmaceutical company. The company is focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. The company's only segment is providing Research and Development services. The company's geographical segment includes India; the USA; Europe and Others. The company generates maximum revenue from the USA. The company earns revenue from the sale of New Chemical Entity (NCE) based Intermediates for CNS disorders.

Suven Life Sciences Headlines

No Headlines